Polaris Partners

Polaris Partners is a venture capital firm based in Boston, Massachusetts, with offices in San Francisco. Founded in 1996, it targets investments in technology and life science companies across the United States and Europe, supporting startups from early formation to profitable growth. The firm's healthcare and biotechnology focus encompasses digital health, consumer-centric care delivery, patient-provider solutions, data science and analytics, as well as therapeutics, genomics and other life science platforms. It backs companies across business-to-business and business-to-consumer models, software as a service, healthcare information technology and health tech sectors, partnering with repeat entrepreneurs to build durable, scale-ready businesses.

Mark Augenstern

Associate

David Barrett

Managing Partner

Marissa Bertorelli

Principal

Alexandra Cantley Ph.D

Partner

Darren Carroll

Partner

Past deals in New York

Nomad Health

Series E in 2024
Nomad Health, Inc. is an online marketplace that connects clinicians with freelance and permanent clinical job opportunities in the United States. Founded in 2015 and based in New York, the company provides a platform where doctors and nurses can search for employment based on various criteria such as location, pay rate, and medical specialty. Nomad Health aims to streamline the healthcare staffing process by replacing traditional methods with a modern, efficient technology platform. The service not only simplifies job searches but also manages digital resumes and credentials, facilitating communication between clinicians and healthcare facilities. This innovative approach addresses the complexities of healthcare staffing, enhancing the experience for both job seekers and providers.

ByHeart

Venture Round in 2024
Founded in 2016, ByHeart is a New York-based company dedicated to producing evolved infant nutrition products. It translates leading scientific research into innovative foods and formulas that prioritize immune, microbiome, cognitive, and digestive health.

Simon Data

Series D in 2023
Simon Data develops a customer data platform designed to enhance campaign performance via precise segmentation and personalization. Its platform identifies purchase intent, predicts churn, estimates customer lifetime value, and enables brands to deliver personalized experiences across channels.

Volastra

Series A in 2023
Volastra Therapeutics, Inc. is a biotechnology company focused on developing innovative therapies for metastatic cancers. Established in 2019 and headquartered in New York, the company leverages unique insights into chromosomal instability to create targeted treatment strategies. Volastra utilizes a library of organoids derived from metastatic cancer samples to better understand tumor spread and identify effective therapeutic approaches. Additionally, the company combines artificial intelligence, bioinformatics, and proprietary imaging techniques, which enhance the ability of healthcare professionals to determine which cancers are more likely to metastasize. This approach aims to facilitate quicker target identification, optimize patient selection for therapies, and ultimately improve patient outcomes.

Nomad Health

Venture Round in 2022
Nomad Health, Inc. is an online marketplace that connects clinicians with freelance and permanent clinical job opportunities in the United States. Founded in 2015 and based in New York, the company provides a platform where doctors and nurses can search for employment based on various criteria such as location, pay rate, and medical specialty. Nomad Health aims to streamline the healthcare staffing process by replacing traditional methods with a modern, efficient technology platform. The service not only simplifies job searches but also manages digital resumes and credentials, facilitating communication between clinicians and healthcare facilities. This innovative approach addresses the complexities of healthcare staffing, enhancing the experience for both job seekers and providers.

Kallyope

Series D in 2022
Kallyope Inc. is a biotechnology company based in New York City that focuses on understanding the gut-brain axis to develop innovative therapeutics and consumer products aimed at enhancing human health. Established in 2014, Kallyope employs advanced technologies, including sequencing, computational biology, neural imaging, and human genetics, to explore gut-brain biology. The company aims to address significant unmet medical needs, such as diabetes, obesity, gut disorders, inflammatory diseases, migraines, and allergies, by creating effective and user-friendly oral agents. Kallyope's team consists of experienced scientists from leading institutions, working alongside a skilled team with a strong track record in drug discovery and development. Through its research, Kallyope seeks to deliver transformative solutions that improve overall health outcomes.

76Bio

Venture Round in 2022
Founded in 2020, 76Bio is a biotechnology company dedicated to developing innovative therapies for patients with life-threatening diseases. It specializes in pioneering targeted protein degraders.

Sonrai Security

Series C in 2021
Sonrai Security provides a comprehensive enterprise identity and data governance platform for AWS, Azure, Google Cloud, and Kubernetes. Its flagship product, Dig, uses advanced graph technology to identify and monitor relationships between identities and data within public clouds. The platform automates workflows, remediation, and prevention capabilities across cloud and security teams, ensuring end-to-end security.

Nomad Health

Series D in 2021
Nomad Health, Inc. is an online marketplace that connects clinicians with freelance and permanent clinical job opportunities in the United States. Founded in 2015 and based in New York, the company provides a platform where doctors and nurses can search for employment based on various criteria such as location, pay rate, and medical specialty. Nomad Health aims to streamline the healthcare staffing process by replacing traditional methods with a modern, efficient technology platform. The service not only simplifies job searches but also manages digital resumes and credentials, facilitating communication between clinicians and healthcare facilities. This innovative approach addresses the complexities of healthcare staffing, enhancing the experience for both job seekers and providers.

ByHeart

Series B in 2021
Founded in 2016, ByHeart is a New York-based company dedicated to producing evolved infant nutrition products. It translates leading scientific research into innovative foods and formulas that prioritize immune, microbiome, cognitive, and digestive health.

Wellthy

Series B in 2021
Wellthy, Inc. is a family care concierge service based in New York, established in 2014. The company specializes in assisting individuals and families managing complex care situations, particularly those involving chronic illnesses, aging-related issues, or disabilities. Wellthy connects families with dedicated Care Coordinators who help navigate the logistical and administrative challenges of caregiving. This includes organizing appointments, managing contacts, and storing essential documents. The service is designed to support families dealing with a range of health conditions, such as dementia, diabetes, heart disease, and cancer, as well as those requiring assistance with childcare and special needs. Through its platform, Wellthy aims to alleviate the burden of care management, allowing families to focus on their loved ones’ well-being.

Thirty Madison

Series C in 2021
Thirty Madison is a digital health company specializing in personalized treatments for chronic conditions. It operates platforms like Keeps (hair loss), Cove (migraines), Picnic (allergies), Facet (skin conditions), and Nurx (sexual health). Founded in 2016, it aims to empower individuals with accessible, effective care tailored to their specific needs.

Volastra

Seed Round in 2021
Volastra Therapeutics, Inc. is a biotechnology company focused on developing innovative therapies for metastatic cancers. Established in 2019 and headquartered in New York, the company leverages unique insights into chromosomal instability to create targeted treatment strategies. Volastra utilizes a library of organoids derived from metastatic cancer samples to better understand tumor spread and identify effective therapeutic approaches. Additionally, the company combines artificial intelligence, bioinformatics, and proprietary imaging techniques, which enhance the ability of healthcare professionals to determine which cancers are more likely to metastasize. This approach aims to facilitate quicker target identification, optimize patient selection for therapies, and ultimately improve patient outcomes.

Egenesis

Series C in 2021
Egenesis is a biotechnology company focused on gene editing and genome engineering to develop human-compatible organs, tissues, and cells for transplantation. Its platform enables the creation of solid organs and therapeutic cells intended for transplantation, addressing the global organ shortage. The company pursues programs in kidney and islet cell transplantation and related regenerative approaches. It is based in Cambridge, Massachusetts, with an additional office in New York.

Sonrai Security

Series B in 2020
Sonrai Security provides a comprehensive enterprise identity and data governance platform for AWS, Azure, Google Cloud, and Kubernetes. Its flagship product, Dig, uses advanced graph technology to identify and monitor relationships between identities and data within public clouds. The platform automates workflows, remediation, and prevention capabilities across cloud and security teams, ensuring end-to-end security.

Neogene Therapeutics

Series A in 2020
Neogene Therapeutics, Inc., founded in 2018 and based in New York, develops innovative T cell therapies aimed at treating cancer. The company specializes in creating personalized engineered T cells that target mutated proteins, known as neo-antigens, found in cancer cells as a result of DNA mutations. By leveraging advanced technologies, Neogene isolates neo-antigen specific T cell receptor genes from tumor biopsies, which are routinely collected during cancer treatment. These tumor-infiltrating lymphocytes often express T cell receptors that can recognize and attack cancer cells displaying neo-antigens. Utilizing state-of-the-art DNA sequencing, synthesis, and genetic screening, Neogene's proprietary platform enables the identification of these specific T cell receptors with high sensitivity and at scale, ultimately enhancing the efficacy of cancer treatments.

Thirty Madison

Series B in 2020
Thirty Madison is a digital health company specializing in personalized treatments for chronic conditions. It operates platforms like Keeps (hair loss), Cove (migraines), Picnic (allergies), Facet (skin conditions), and Nurx (sexual health). Founded in 2016, it aims to empower individuals with accessible, effective care tailored to their specific needs.

ByHeart

Series A in 2020
Founded in 2016, ByHeart is a New York-based company dedicated to producing evolved infant nutrition products. It translates leading scientific research into innovative foods and formulas that prioritize immune, microbiome, cognitive, and digestive health.

Kallyope

Series C in 2020
Kallyope Inc. is a biotechnology company based in New York City that focuses on understanding the gut-brain axis to develop innovative therapeutics and consumer products aimed at enhancing human health. Established in 2014, Kallyope employs advanced technologies, including sequencing, computational biology, neural imaging, and human genetics, to explore gut-brain biology. The company aims to address significant unmet medical needs, such as diabetes, obesity, gut disorders, inflammatory diseases, migraines, and allergies, by creating effective and user-friendly oral agents. Kallyope's team consists of experienced scientists from leading institutions, working alongside a skilled team with a strong track record in drug discovery and development. Through its research, Kallyope seeks to deliver transformative solutions that improve overall health outcomes.

Volastra

Seed Round in 2020
Volastra Therapeutics, Inc. is a biotechnology company focused on developing innovative therapies for metastatic cancers. Established in 2019 and headquartered in New York, the company leverages unique insights into chromosomal instability to create targeted treatment strategies. Volastra utilizes a library of organoids derived from metastatic cancer samples to better understand tumor spread and identify effective therapeutic approaches. Additionally, the company combines artificial intelligence, bioinformatics, and proprietary imaging techniques, which enhance the ability of healthcare professionals to determine which cancers are more likely to metastasize. This approach aims to facilitate quicker target identification, optimize patient selection for therapies, and ultimately improve patient outcomes.

Simon Data

Series C in 2019
Simon Data develops a customer data platform designed to enhance campaign performance via precise segmentation and personalization. Its platform identifies purchase intent, predicts churn, estimates customer lifetime value, and enables brands to deliver personalized experiences across channels.

Nomad Health

Series C in 2019
Nomad Health, Inc. is an online marketplace that connects clinicians with freelance and permanent clinical job opportunities in the United States. Founded in 2015 and based in New York, the company provides a platform where doctors and nurses can search for employment based on various criteria such as location, pay rate, and medical specialty. Nomad Health aims to streamline the healthcare staffing process by replacing traditional methods with a modern, efficient technology platform. The service not only simplifies job searches but also manages digital resumes and credentials, facilitating communication between clinicians and healthcare facilities. This innovative approach addresses the complexities of healthcare staffing, enhancing the experience for both job seekers and providers.

Ajax Health

Series C in 2019
Ajax Health is a venture capital firm dedicated to the healthcare sector. It invests across stages in medical devices, medtech, healthcare services, digital health, biotechnology and healthcare information technology, aiming to advance innovative solutions that address major healthcare challenges. Founded in 2017, the firm is headquartered in Menlo Park, California, with an additional office in New York City. Ajax Health seeks to accelerate medical innovation through capital and capabilities to support portfolio companies.

Quartet Health

Series D in 2019
Founded in 2014, Quartet Health operates a cloud-based platform facilitating communication between medical providers and behavioral health specialists for improved patient care. The platform works with health plans and systems to provide actionable insights on behavioral health conditions, enhancing patient outcomes.

Ajax Health

Series C in 2019
Ajax Health is a venture capital firm dedicated to the healthcare sector. It invests across stages in medical devices, medtech, healthcare services, digital health, biotechnology and healthcare information technology, aiming to advance innovative solutions that address major healthcare challenges. Founded in 2017, the firm is headquartered in Menlo Park, California, with an additional office in New York City. Ajax Health seeks to accelerate medical innovation through capital and capabilities to support portfolio companies.

Wellthy

Series A in 2019
Wellthy, Inc. is a family care concierge service based in New York, established in 2014. The company specializes in assisting individuals and families managing complex care situations, particularly those involving chronic illnesses, aging-related issues, or disabilities. Wellthy connects families with dedicated Care Coordinators who help navigate the logistical and administrative challenges of caregiving. This includes organizing appointments, managing contacts, and storing essential documents. The service is designed to support families dealing with a range of health conditions, such as dementia, diabetes, heart disease, and cancer, as well as those requiring assistance with childcare and special needs. Through its platform, Wellthy aims to alleviate the burden of care management, allowing families to focus on their loved ones’ well-being.

Sonrai Security

Series A in 2019
Sonrai Security provides a comprehensive enterprise identity and data governance platform for AWS, Azure, Google Cloud, and Kubernetes. Its flagship product, Dig, uses advanced graph technology to identify and monitor relationships between identities and data within public clouds. The platform automates workflows, remediation, and prevention capabilities across cloud and security teams, ensuring end-to-end security.

Kallyope

Series B in 2018
Kallyope Inc. is a biotechnology company based in New York City that focuses on understanding the gut-brain axis to develop innovative therapeutics and consumer products aimed at enhancing human health. Established in 2014, Kallyope employs advanced technologies, including sequencing, computational biology, neural imaging, and human genetics, to explore gut-brain biology. The company aims to address significant unmet medical needs, such as diabetes, obesity, gut disorders, inflammatory diseases, migraines, and allergies, by creating effective and user-friendly oral agents. Kallyope's team consists of experienced scientists from leading institutions, working alongside a skilled team with a strong track record in drug discovery and development. Through its research, Kallyope seeks to deliver transformative solutions that improve overall health outcomes.

Twistlock

Series C in 2018
Twistlock Inc. is a provider of comprehensive security solutions for cloud-native applications, focusing on Docker container security for DevOps environments. Founded in 2015, the company offers a suite of products designed to protect applications throughout their development lifecycle and into production. Its flagship product, Twistlock, enables developers and security teams to safeguard container-based applications with features such as vulnerability management, compliance, access control, and runtime defense. Twistlock's Trust component scans images and registries to identify vulnerabilities and configuration errors, while Twistlock Runtime delivers real-time threat protection and policy enforcement. The company is trusted by a significant portion of the Fortune 100 and is headquartered in Portland, Oregon, with additional offices in New York City, Baton Rouge, London, and Herzliya, Israel. As of July 2019, Twistlock operates as a subsidiary of Palo Alto Networks, Inc.

Simon Data

Series B in 2018
Simon Data develops a customer data platform designed to enhance campaign performance via precise segmentation and personalization. Its platform identifies purchase intent, predicts churn, estimates customer lifetime value, and enables brands to deliver personalized experiences across channels.

Ajax Health

Series B in 2018
Ajax Health is a venture capital firm dedicated to the healthcare sector. It invests across stages in medical devices, medtech, healthcare services, digital health, biotechnology and healthcare information technology, aiming to advance innovative solutions that address major healthcare challenges. Founded in 2017, the firm is headquartered in Menlo Park, California, with an additional office in New York City. Ajax Health seeks to accelerate medical innovation through capital and capabilities to support portfolio companies.

Nomad Health

Series B in 2018
Nomad Health, Inc. is an online marketplace that connects clinicians with freelance and permanent clinical job opportunities in the United States. Founded in 2015 and based in New York, the company provides a platform where doctors and nurses can search for employment based on various criteria such as location, pay rate, and medical specialty. Nomad Health aims to streamline the healthcare staffing process by replacing traditional methods with a modern, efficient technology platform. The service not only simplifies job searches but also manages digital resumes and credentials, facilitating communication between clinicians and healthcare facilities. This innovative approach addresses the complexities of healthcare staffing, enhancing the experience for both job seekers and providers.

Quentis Therapeutics

Series A in 2018
Quentis Therapeutics, Inc. is a biotechnology company founded in 2016 and based in New York, specializing in the development of cancer immunotherapies. The company's innovative therapeutics focus on modulating endoplasmic reticulum (ER) stress response pathways within the tumor microenvironment. By targeting these pathways, Quentis Therapeutics aims to enhance the immune system's ability to combat cancer, thereby providing patients with access to novel treatment options. The company's approach seeks to translate cutting-edge biological insights into effective therapeutic strategies that can improve anti-tumor immunity.

Kallyope

Series B in 2018
Kallyope Inc. is a biotechnology company based in New York City that focuses on understanding the gut-brain axis to develop innovative therapeutics and consumer products aimed at enhancing human health. Established in 2014, Kallyope employs advanced technologies, including sequencing, computational biology, neural imaging, and human genetics, to explore gut-brain biology. The company aims to address significant unmet medical needs, such as diabetes, obesity, gut disorders, inflammatory diseases, migraines, and allergies, by creating effective and user-friendly oral agents. Kallyope's team consists of experienced scientists from leading institutions, working alongside a skilled team with a strong track record in drug discovery and development. Through its research, Kallyope seeks to deliver transformative solutions that improve overall health outcomes.

Quartet Health

Series C in 2018
Founded in 2014, Quartet Health operates a cloud-based platform facilitating communication between medical providers and behavioral health specialists for improved patient care. The platform works with health plans and systems to provide actionable insights on behavioral health conditions, enhancing patient outcomes.

Twistlock

Series B in 2017
Twistlock Inc. is a provider of comprehensive security solutions for cloud-native applications, focusing on Docker container security for DevOps environments. Founded in 2015, the company offers a suite of products designed to protect applications throughout their development lifecycle and into production. Its flagship product, Twistlock, enables developers and security teams to safeguard container-based applications with features such as vulnerability management, compliance, access control, and runtime defense. Twistlock's Trust component scans images and registries to identify vulnerabilities and configuration errors, while Twistlock Runtime delivers real-time threat protection and policy enforcement. The company is trusted by a significant portion of the Fortune 100 and is headquartered in Portland, Oregon, with additional offices in New York City, Baton Rouge, London, and Herzliya, Israel. As of July 2019, Twistlock operates as a subsidiary of Palo Alto Networks, Inc.

B12

Series A in 2016
B12 operates a human-assisted AI platform that streamlines website design processes. It offers Orchestra, an online tool integrating with third-party platforms like e-commerce and blogging services, alerting experts to web design quality issues.

Quartet Health

Series B in 2016
Founded in 2014, Quartet Health operates a cloud-based platform facilitating communication between medical providers and behavioral health specialists for improved patient care. The platform works with health plans and systems to provide actionable insights on behavioral health conditions, enhancing patient outcomes.

Kallyope

Series A in 2015
Kallyope Inc. is a biotechnology company based in New York City that focuses on understanding the gut-brain axis to develop innovative therapeutics and consumer products aimed at enhancing human health. Established in 2014, Kallyope employs advanced technologies, including sequencing, computational biology, neural imaging, and human genetics, to explore gut-brain biology. The company aims to address significant unmet medical needs, such as diabetes, obesity, gut disorders, inflammatory diseases, migraines, and allergies, by creating effective and user-friendly oral agents. Kallyope's team consists of experienced scientists from leading institutions, working alongside a skilled team with a strong track record in drug discovery and development. Through its research, Kallyope seeks to deliver transformative solutions that improve overall health outcomes.

Quartet Health

Series A in 2015
Founded in 2014, Quartet Health operates a cloud-based platform facilitating communication between medical providers and behavioral health specialists for improved patient care. The platform works with health plans and systems to provide actionable insights on behavioral health conditions, enhancing patient outcomes.

Jibe

Series C in 2014
Jibe Inc. is a provider of cloud-based recruiting technology solutions designed to assist talent acquisition teams in identifying, attracting, and engaging candidates globally. Founded in 2009 and based in New York, the company offers the Jibe Recruiting Cloud, a software-as-a-service platform that streamlines the hiring process. This platform features various applications, including tools for applying to jobs from multiple devices, enhancing employee referrals, and distributing job postings across various channels. Jibe's solutions cater to the needs of Fortune 500 companies, enabling them to optimize candidate experiences and leverage social networks for recruitment. With strategic partnerships with industry leaders such as Google and LinkedIn, Jibe continues to innovate within the talent acquisition space. It operates as a subsidiary of iCIMS, Inc. since 2019.

Adcade

Series A in 2013
Adcade is a New York-based company founded in 2012 that specializes in providing media solutions for mobile and tablet platforms, catering to the needs of advertisers, publishers, and developers. The company develops an animation tool designed to facilitate the creation and publication of multi-screen HTML5 advertisements. This tool enables clients to monetize content effectively and offers advertisers opportunities for cross-platform engagement. Additionally, it allows for the conversion of Photoshop designs directly into interactive projects, integrating assets and code to ensure compatibility across various devices and ad servers. Adcade aims to enhance the advertising landscape by delivering effective solutions that work for a diverse range of stakeholders.

Jibe

Series B in 2013
Jibe Inc. is a provider of cloud-based recruiting technology solutions designed to assist talent acquisition teams in identifying, attracting, and engaging candidates globally. Founded in 2009 and based in New York, the company offers the Jibe Recruiting Cloud, a software-as-a-service platform that streamlines the hiring process. This platform features various applications, including tools for applying to jobs from multiple devices, enhancing employee referrals, and distributing job postings across various channels. Jibe's solutions cater to the needs of Fortune 500 companies, enabling them to optimize candidate experiences and leverage social networks for recruitment. With strategic partnerships with industry leaders such as Google and LinkedIn, Jibe continues to innovate within the talent acquisition space. It operates as a subsidiary of iCIMS, Inc. since 2019.

Fancy Hands

Venture Round in 2012
Fancy Hands, Inc. is a New York-based company that provides a range of assistant services aimed at supporting both individuals and businesses. Founded in 2010, the company offers solutions that include managing expense reports, creating target lists, finding contact information, and performing data entry. Additionally, Fancy Hands assists with personal tasks such as scheduling appointments, planning events, and making purchases. The company's personal assistant application enables users to manage to-do lists, conduct research, and organize their calendars efficiently. It caters to various needs, from handling business-related inquiries to personal errands, thus enhancing productivity for its users. Fancy Hands also provides tools and software development kits for developers, further extending its service offerings.

Wantful

Series A in 2012
Wantful, a San Francisco, CA- and NYC-based gift-giving service. Founded in 2011 by by designer and serial entrepreneur John Poisson, CEO, the company also expects to make a number of key hires in both its San Francisco and New York City offices in order to grow its engineering, merchandising and operations teams.

Jibe

Series A in 2011
Jibe Inc. is a provider of cloud-based recruiting technology solutions designed to assist talent acquisition teams in identifying, attracting, and engaging candidates globally. Founded in 2009 and based in New York, the company offers the Jibe Recruiting Cloud, a software-as-a-service platform that streamlines the hiring process. This platform features various applications, including tools for applying to jobs from multiple devices, enhancing employee referrals, and distributing job postings across various channels. Jibe's solutions cater to the needs of Fortune 500 companies, enabling them to optimize candidate experiences and leverage social networks for recruitment. With strategic partnerships with industry leaders such as Google and LinkedIn, Jibe continues to innovate within the talent acquisition space. It operates as a subsidiary of iCIMS, Inc. since 2019.

Cardlytics

Series C in 2010
Cardlytics operates an advertising platform within financial institutions' digital channels, enabling marketers to reach consumers through trusted online and mobile banking channels. It uses purchase-based intelligence to make marketing more relevant and measurable, partnering with over 1,500 financial institutions worldwide.

Jibe

Seed Round in 2010
Jibe Inc. is a provider of cloud-based recruiting technology solutions designed to assist talent acquisition teams in identifying, attracting, and engaging candidates globally. Founded in 2009 and based in New York, the company offers the Jibe Recruiting Cloud, a software-as-a-service platform that streamlines the hiring process. This platform features various applications, including tools for applying to jobs from multiple devices, enhancing employee referrals, and distributing job postings across various channels. Jibe's solutions cater to the needs of Fortune 500 companies, enabling them to optimize candidate experiences and leverage social networks for recruitment. With strategic partnerships with industry leaders such as Google and LinkedIn, Jibe continues to innovate within the talent acquisition space. It operates as a subsidiary of iCIMS, Inc. since 2019.

JibJab Bros Studios

Series C in 2009
JibJab Catapult CA LLC, commonly known as JibJab, is an online studio that specializes in creating and distributing social expression content, including e-cards, branded satires, and humorous messages. Founded in 1999 by two brothers in a Brooklyn garage, the company has evolved into a prominent provider of digital media services, helping individuals share funny and entertaining content online. JibJab’s offerings include a variety of digital products such as music videos, GIFs, and the JibJab Camera app. With a team of artists and technologists based in Los Angeles, JibJab aims to enhance the digital experience by enabling users to express humor and joy in their everyday communications. Since its incorporation in 2018, the company has continued to innovate in the realm of online entertainment, striving to bring happiness to billions of people through its creative content.

JibJab Bros Studios

Series B in 2007
JibJab Catapult CA LLC, commonly known as JibJab, is an online studio that specializes in creating and distributing social expression content, including e-cards, branded satires, and humorous messages. Founded in 1999 by two brothers in a Brooklyn garage, the company has evolved into a prominent provider of digital media services, helping individuals share funny and entertaining content online. JibJab’s offerings include a variety of digital products such as music videos, GIFs, and the JibJab Camera app. With a team of artists and technologists based in Los Angeles, JibJab aims to enhance the digital experience by enabling users to express humor and joy in their everyday communications. Since its incorporation in 2018, the company has continued to innovate in the realm of online entertainment, striving to bring happiness to billions of people through its creative content.

JibJab Bros Studios

Series A in 2006
JibJab Catapult CA LLC, commonly known as JibJab, is an online studio that specializes in creating and distributing social expression content, including e-cards, branded satires, and humorous messages. Founded in 1999 by two brothers in a Brooklyn garage, the company has evolved into a prominent provider of digital media services, helping individuals share funny and entertaining content online. JibJab’s offerings include a variety of digital products such as music videos, GIFs, and the JibJab Camera app. With a team of artists and technologists based in Los Angeles, JibJab aims to enhance the digital experience by enabling users to express humor and joy in their everyday communications. Since its incorporation in 2018, the company has continued to innovate in the realm of online entertainment, striving to bring happiness to billions of people through its creative content.

LRN

Series B in 2006
LRN Corporation specializes in providing ethics and compliance (E&C) knowledge solutions to organizations globally. Founded in 1992 and headquartered in Los Angeles, the company offers a range of services including online courses on essential topics such as anti-bribery and trade controls, along with custom training materials accessible via mobile devices. LRN also provides advisory services related to code of conduct development, governance assessments, and risk management. Its solutions incorporate innovative approaches such as gamification, adaptive learning, and augmented reality applications to enhance compliance programs. By focusing on promoting ethical conduct and principled performance, LRN aims to align employee behaviors with corporate values, thereby fostering a sustainable organizational culture. The company operates additional offices in New York, London, Montreal, Paris, Santiago, Mumbai, and Australia.

Advion

Series B in 2002
Advion is a global company founded in 1993 and headquartered in New York, specializing in systems and consumables for life science research. It provides a range of biochemistry analysis equipment, including microfluidic devices and mass spectrometry products aimed at supporting various sectors such as biopharmaceuticals, academic and government research, and industrial chemistry. Advion’s offerings include purpose-built mass spectrometers, nanoelectrospray ionization sources, and flow-chemistry synthesis systems, catering to the needs of pharmaceutical companies, research agencies, and universities worldwide.

Invisible Hands Networks

Seed Round in 2002
Invisible Hands Networks, Inc. is a technology company that specializes in developing Merkato, an open software platform designed for real-time, market-based pricing and allocation of Internet Protocol (IP) bandwidth. The platform facilitates transactions between sellers, such as IP network service providers, and buyers, including content providers, enterprises, and Internet Service Providers (ISPs). Merkato allows sellers to optimize revenue by filling off-peak capacity and launching new services based on market demand. For buyers, it offers flexible, on-demand access to bandwidth at fair market prices, along with improved guarantees and quality of service. The platform supports real-time spot and reservation marketplaces, automates price discovery and negotiation, and employs intelligent agents for advanced transaction strategies. Founded in 1998 and headquartered in New York, Invisible Hands Networks aims to enhance the efficiency and effectiveness of bandwidth transactions in the digital marketplace.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.